WHO Essential Medicines List2023WHO Expert CommitteeEN
WHO EML 2023: Section 9 - Antiparkinsonism Medicines
Zusammenfassung
WHO ESSENTIAL MEDICINES LIST (EML) 2023: Section 9 - Antiparkinsonism Medicines
Medicines for the treatment of Parkinson disease and drug-induced extrapyramidal symptoms.
Number of essential medicines in this section: 2
=== MEDICINES ===
- Biperiden | Formulations: Tablet; Injection | Strength: 2 mg; 5 mg/mL | Route: Oral/IV/IM | Note: Anticholinergic - drug-induced EPS
- Levodopa + Carbidopa | Formulations: Tablet | Strength: 100+25 mg; 250+25 mg | Route: Oral | Note: Gold standard for PD
=
Fragen zu diesem Thema?
ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.
Jetzt auf ClariMed suchenVerwandte Leitlinien
WHO Essential Medicines List2023
WHO EML 2023: Section 13 - Psychotherapeutic Medicines
WHO Essential Medicines List2023
WHO EML 2023: Section 5 - Anticonvulsants / Antiepileptics
WHO Essential Medicines List2023
WHO EML 2023: Section 7 - Antimigraine Medicines
WHO Essential Medicines List2023
WHO EML 2023: Section 10 - Medicines Affecting the Blood and Cardiovascular System
WHO Essential Medicines List2023
WHO EML 2023: Section 2 - Analgesics, Antipyretics, Non-steroidal Anti-inflammatory Medicines (NSAIMs), and Medicines Used to Treat Gout
WHO Essential Medicines List2023
WHO EML 2023: Section 4 - Antidotes and Other Substances Used in Poisonings
WHO Essential Medicines List2023
WHO EML 2023: Section 12 - Medicines for Diabetes
WHO Essential Medicines List2023